Driscoll pharmacist appointed Congressional Captain

Community NewsPublisher's Picks
223

Translate to Spanish or other 102 languages!

Jennifer Witte, PharmD is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas

Mega Doctor News

- Advertisement -

Jennifer Witte, PharmD, a dedicated cystic fibrosis clinical pharmacist for the Driscoll Children’s Hospital Cystic Fibrosis Center who is certified by the Society of Infectious Diseases Pharmacists (SIDP) in antimicrobial stewardship, was recently appointed the Congressional Captain for TX-27 by the Cystic Fibrosis Foundation CF Advocacy Department. She is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas. They met to discuss cystic fibrosis and the PASTEUR Act, which is a bill introduced to the House and Senate that aims to improve antimicrobial stewardship and the development of antibiotics.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Dr. Hochman Funds Twentieth Annual Education Grant
Next article
Drugs used by some Type 2 diabetics may lessen their risk for severe COVID-19 complications

More Articles

Researchers Discover How Aggressive Brain Tumors Outsmart Treatment

For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, treatment typically works at first. However, the cancer almost always returns, and when it does, it frequently stops responding to treatment.

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 
- Advertisement -